The Value of Diaphragmatic Ultrasound in Non-invasive Oxygen Therapy

April 20, 2020 updated by: wang kaifei, Chinese PLA General Hospital

Department of Pulmonary & Critical Care Medicine, Chinese PLA General Hospital

In this study, a single-center, prospective, observational study was adopted to set the cut-off values of diaphragmatic ultrasound results and arterial blood gas results,with the choice of non-invasive oxygen therapy as the gold standard,so as to evaluate the diagnostic value of diaphragmatic ultrasound in the selection of non-invasive oxygen therapy.

Study Overview

Status

Unknown

Detailed Description

  1. the cut-off values of diaphragmatic ultrasound results and arterial blood gas results were established by the selection results of non-invasive oxygen therapy of 120 patients in the intensive care unit and using receiver operating Characteristic curve.

diaphragm excursion,inspiratory time,diaphragm contraction velocity,diaphragm excursion time

Study Type

Observational

Enrollment (Anticipated)

120

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Beijing
      • Beijing, Beijing, China, 100853
        • Recruiting
        • Department of Pulmonary and Critical Care Medicine, Chinese PLA General Hospital
        • Contact:
          • lixin xie, doctor

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

patients older than 18 years without Invasive mechanical ventilation when entering the intensive care unit.

Description

Inclusion Criteria:

  • patients older than 18 years
  • without Invasive mechanical ventilation when entering the intensive care unit.

Exclusion Criteria:

  • have noninvasive ventilation or high flow nasal cannula contraindications
  • history of neuromuscular disease chest wall deformities
  • previously assessed diaphragmatic palsy
  • shock or severe hemodynamic instability
  • known pregnancy, and/or need for immediate endotracheal intubation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
conventional oxygen therapy
Continuous use of current oxygen therapy
high flow nasal cannula
change the oxygen therapy to high flow nasal cannula
Noninvasive ventilation
change the oxygen therapy to noninvasive ventilation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
the data diaphragmatic ultrasound
Time Frame: When the intervention which is the first time to change the oxygen therapy
Record the data at the baseline and intervention
When the intervention which is the first time to change the oxygen therapy

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Arterial blood gas analysis results
Time Frame: When the intervention which is the first time to change the oxygen therapy
Record the data at the baseline and intervention
When the intervention which is the first time to change the oxygen therapy

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2018

Primary Completion (Anticipated)

April 30, 2020

Study Completion (Anticipated)

August 31, 2020

Study Registration Dates

First Submitted

March 24, 2020

First Submitted That Met QC Criteria

April 20, 2020

First Posted (Actual)

April 21, 2020

Study Record Updates

Last Update Posted (Actual)

April 21, 2020

Last Update Submitted That Met QC Criteria

April 20, 2020

Last Verified

April 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • 2018TM-03

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Intensive Care Unit

3
Subscribe